With the IPO market moribund, and the venture capital sector searching for a new investment model in an environment characterized by risk aversion and a shrunken pool of limited partner funding sources, exit by acquisition is emerging as the most important route to financial return for entrepreneurs and investors. A robust understanding of the wants and needs of potential acquirers is therefore essential to the development of a successful medical device startup business strategy and plan.
Join a panel of business development executives from major device companies, moderated by one of the region’s leading life sciences entrepreneurs and venture capital veterans, for an enlightening discussion of how their companies approach acquisition targeting, evaluation and strategy.
Moderator:
John Brooks
Managing Director, Healthcare Capital Consulting
Medfield, MA
Founding Partner, Prism VentureWorks
Panelists:
Dennis Crowley
Vice President for Business Development, Covidien
Mansfield, MA
Mike Landsittel
Director of Business Development, Genzyme Biosurgery
Cambridge, MA
Event Champion:
Edward E. Berger
Principal, Larchmont Strategic Advisors
Chestnut Hill, MA
Wed Dec 9, 2009 5:30 PM
Cash or check (to "MedDev Group, Inc.") will be collected at the door. - Registration closes on December 8, 2009 at 8:00 PM
Event Fee Member Non-member
Pre-registration $20 $20 first visit
$30 subsequently
Registration at the door $30 $30 first visit
$40 subsequently
Location: Foley Hoag Emerging Enterprise Center, Bay Colony Corporate Center, 1000 Winter Street, Suite 4000, North Entrance, Waltham, Massachusetts 02451-1436
For more information:
Contact: Julie Lavallee
Email: julie@
